Literature DB >> 9465084

Primary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokines.

E Barker1, K N Bossart, J A Levy.   

Abstract

The productive infection of human monocyte-derived macrophages (Mphi) by HIV was suppressed by primary CD8+ cells from asymptomatic HIV-infected individuals. This anti-HIV response was noncytotoxic; removal of the CD8+ cells from the infected Mphi leads to virus production. CD8+ cells inhibited HIV replication when separated from the infected Mphi by a transwell filter insert, indicating a diffusible factor made by the CD8+ cells suppressed productive infection of Mphi. Three beta-chemokines, which can be secreted by activated CD8+ cells, RANTES (regulated on activation normal T cell expressed and secreted), macrophage inflammatory protein (MIP)-1alpha and MIP-1beta prevented HIV replication in the Mphi cultures. In addition, incubation of acutely infected Mphi with a mixture of neutralizing antibodies to RANTES, MIP-1alpha, and MIP-1beta enhanced virus replication. Nevertheless, neutralization of beta-chemokines with specific antibodies did not abolish the suppression by CD8+ cells of HIV replication in Mphi. Thus, even though beta-chemokines decrease HIV replication in Mphi, these cytokines are not responsible for the ability of CD8+ cells to inhibit HIV production in these cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9465084      PMCID: PMC19166          DOI: 10.1073/pnas.95.4.1725

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Do beta-chemokines have clinical relevance in HIV infection?

Authors:  C E Mackewicz; E Barker; G Greco; G Reyes-Teran; J A Levy
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

2.  Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals.

Authors:  J A Levy; J Shimabukuro
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

Review 3.  HIV entry and tropism: the chemokine receptor connection.

Authors:  E A Berger
Journal:  AIDS       Date:  1997       Impact factor: 4.177

4.  In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).

Authors:  J K Nicholson; G D Cross; C S Callaway; J S McDougal
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

5.  The role of mononuclear phagocytes in HTLV-III/LAV infection.

Authors:  S Gartner; P Markovits; D M Markovitz; M H Kaplan; R C Gallo; M Popovic
Journal:  Science       Date:  1986-07-11       Impact factor: 47.728

6.  Macrophages as a source of HIV during opportunistic infections.

Authors:  J M Orenstein; C Fox; S M Wahl
Journal:  Science       Date:  1997-06-20       Impact factor: 47.728

7.  Use of gelatin/plasma coated flasks for isolating human peripheral blood monocytes.

Authors:  B Freundlich; N Avdalovic
Journal:  J Immunol Methods       Date:  1983-08-12       Impact factor: 2.303

8.  Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation.

Authors:  S Rana; G Besson; D G Cook; J Rucker; R J Smyth; Y Yi; J D Turner; H H Guo; J G Du; S C Peiper; E Lavi; M Samson; F Libert; C Liesnard; G Vassart; R W Doms; M Parmentier; R G Collman
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

9.  Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions.

Authors:  A D Hoffman; B Banapour; J A Levy
Journal:  Virology       Date:  1985-12       Impact factor: 3.616

10.  C-C chemokines released by lipopolysaccharide (LPS)-stimulated human macrophages suppress HIV-1 infection in both macrophages and T cells.

Authors:  A Verani; G Scarlatti; M Comar; E Tresoldi; S Polo; M Giacca; P Lusso; A G Siccardi; D Vercelli
Journal:  J Exp Med       Date:  1997-03-03       Impact factor: 14.307

View more
  14 in total

1.  HIV-1 dynamics revisited: biphasic decay by cytotoxic T lymphocyte killing?

Authors:  R A Arnaout; M A Nowak; D Wodarz
Journal:  Proc Biol Sci       Date:  2000-07-07       Impact factor: 5.349

2.  The synthetic immunomodulator murabutide controls human immunodeficiency virus type 1 replication at multiple levels in macrophages and dendritic cells.

Authors:  E C Darcissac; M J Truong; J Dewulf; Y Mouton; A Capron; G M Bahr
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Alpha-defensins inhibit HIV infection of macrophages through upregulation of CC-chemokines.

Authors:  Chang-Jiang Guo; Ning Tan; Li Song; Steven D Douglas; Wen-Zhe Ho
Journal:  AIDS       Date:  2004-05-21       Impact factor: 4.177

Review 4.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

5.  A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation.

Authors:  Theresa Li-Yun Chang; Arevik Mosoian; Richard Pine; Mary E Klotman; John P Moore
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

6.  The CD8+ cell noncytotoxic anti-HIV response can be blocked by protease inhibitors.

Authors:  Carl E Mackewicz; Charles S Craik; Jay A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-06       Impact factor: 11.205

7.  Two overlapping subdominant epitopes identified by DNA immunization induce protective CD8(+) T-cell populations with differing cytolytic activities.

Authors:  F Rodriguez; M K Slifka; S Harkins; J L Whitton
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

8.  Administration of recombinant rhesus interleukin-12 during acute simian immunodeficiency virus (SIV) infection leads to decreased viral loads associated with prolonged survival in SIVmac251-infected rhesus macaques.

Authors:  A A Ansari; A E Mayne; J B Sundstrom; P Bostik; B Grimm; J D Altman; F Villinger
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

9.  Changes in soluble factor-mediated CD8+ cell-derived antiviral activity in cynomolgus macaques infected with simian immunodeficiency virus SIVmac251: relationship to biological markers of progression.

Authors:  Vincent Dioszeghy; Kadija Benlhassan-Chahour; Benoit Delache; Nathalie Dereuddre-Bosquet; Celine Aubenque; Gabriel Gras; Roger Le Grand; Bruno Vaslin
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

10.  CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition.

Authors:  Theresa Li-Yun Chang; Fleur François; Arevik Mosoian; Mary E Klotman
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.